The LabRoots
Molecular Diagnostics virtual conference is coming up next week! We are excited to bring you this inaugural event in a field that is growing so quickly and bringing new advancements to the lab and clinic.
The conference is a premiere venue for scientists, technologists, and professionals to discuss and present the newest developments in molecular diagnostics testing. Molecular diagnostic testing is relevant to both identifying markers associated with disease, and clinical applications such as infectious disease detection, oncology, pharmacogenomics, or genetic disease screening. You can attend this online event at no charge.
Join LabRoots in bringing together the molecular diagnostics community. Attend webcasts with top experts and interact with speakers during the live Q&A sessions. Earn continuing education credits and network with peers. Enjoy the complementary conference from your desk with no need for travel, and explore the virtual exhibit hall to learn about the latest technologies and techniques for your lab.
Use #LRmoldx to follow the conversation and don’t miss this great opportunity!
Featured speakers include:
Microbiome Biomarker Discovery for Diagnostic and Therapeutic Applications
Todd DeSantis - Director of Bioinformatics, Second Genome, Inc.
Keynote Speaker: The Laboratory-Clinical Partnership: Opportunities and Challenges
William M. VALENTI, M.D. - Senior Vice President for Organizational Advancement, Co-Founder, and Staff Physician, Trillium Health
Validation and Implementation of Whole-Exome Sequencing to Guide Precision Cancer Care
Hanna Rennert, PhD, F.A.C.M.G - Assistant Professor of Pathology and Laboratory Medicine, Weill Medical College of Cornell University
EFIRM Liquid Biopsy
David T.W. Wong DMD, DMSc - Associate Dean of Research and Director of the Oral/Head and Neck Oncology Research Center, UCLA
The application of molecular diagnostics to stained cytology smears
Maja Oktay, MD, PhD - Associate Professor of Pathology, Albert Einstein College of Medicine
Sumanta Goswami, PhD - Associate Professor of Biology, Albert Einstein College of Medicine
Keynote Speaker: Recent Progress in Predictive Biomarker Testing in Oncology
John W Longshore, Ph.D., FACMG - Director of Molecular Pathology, Carolinas Pathology Group
2016 and Beyond: Reimbursement and Regulatory Lessons for Another Year
Rina Wolf, MHA - VP Commercialization Strategies, Consulting & Industry Affairs, XIFIN, Inc.
Ligand-Targeted Therapies for Cancer and Autoimmune Diseases
Philip S. Low, PhD - Director of the Purdue Center for Drug Discovery Ralph C. Corley Distinguished Professor Department of Chemistry, Purdue University
Molecular Medicine in Healthcare: The Personalized Medicine Initiative
Pieter Cullis, PhD - Chair, Personalized Medicine Initiative, Director, Life Sciences Institute, University of British Columbia
Introduction to exosomes and other extracellular vesicles the “the bodies molecular internet” for personalized & precision medicine.
Rey Magana - Cofounder of the EXO Incubator, Pioneer in exosome nucleic acid technologies
The impact of precise medicine on the practice of classical pathology -- What are some of the challenges and opportunities?
Michael J. Donovan, MD, PhD - Board certified anatomic and clinical pathologist, Icahn School of Medicine at Mount Sinai